Organization Profile

You just read:

Quest PharmaTech Signs License Agreement with OncoCare Therapeutics to Develop and Commercialize Targeted Cancer Therapy Technology in the U.S.

News provided by

Quest PharmaTech Inc.

Nov 28, 2018, 09:30 ET